Last update :
19/11/2024
InfoStab
Infostab
List of drugs
List of drugs
Summary lists
Summary lists
Search for compatibilities
Search for compatibilities
Y-site compatibility table
Y-site compatibility table
References
References
Research teams
Research teams
valistab
valistab
Poster
Poster
Links
Links
Sponsors
Sponsors
Authors
Authors
User’s guide
User’s guide
Newsletter
Newsletter
Various   Neostigmine methylsulfate  
injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers
Adwigmine Egypt
Amostigmine Egypt
Beemine India
Bloxiverz
Epistigmine Egypt
Fadastigmina Argentina, Italy, Portugal
Ipostigmine Iran
Miostin Romania
Neostig Germany
Neostigmin Germany, Sweden
Neostigmina Argentina, Chile, Colombia, Ecuador, Peru, Portugal, Spain, Venezuela
Neostigmine Australia, Canada, Egypt, Great Britain, Greece, Ireland, Malaysia, Netherlands, New Zealand, Saudi Arabia, Turkey
Neostigmine methylsulfate Canada
Neostigten Peru
Normastigmin Austria
Planstigmin Turkey
Polstigminum Poland
Prostigmin Austria, Belgium, Greece, Malaysia, Netherlands, Switzerland
Prostigmina Italy
Prostigmine Belgium, Chile, Colombia, Egypt, France, Luxembourg, Mexico, Morocco, Spain, United Arab Emirates, Venezuela
Setisin Malaysia
Stigmosan Hungary
Tigmin Peru
Visulmin Mexico
References   injection   References : Neostigmine methylsulfate  
Type Publication
815 Journal Stewart JT, Warren FW, King DT, Venkateshwaran TG, Fox JL.
Stability of ondansetron hydrochloride and 12 medications in plastic syringes.
Am J Health-Syst Pharm 1998 ; 55: 2630-2634.
1200 Journal Chaudry IA, Bruey KP, Hurlburt LE, Oden EM.
Compatibility of netilmycin sulfate injection with commonly used intravenous injections and additives.
Am J Hosp Pharm 1981 ; 38: 1737-1742.
1228 Journal Allen LV, Stiles ML.
Compatibility of various admixtures at Y-injection sites of intravenous administration sets. Part2.
Am J Hosp Pharm 1981 ; 38: 380-381.
1682 Journal Storms M, Stewart JT, Warren FW.
Stability of neostigmine methylsulfate injection at ambient temperature and 4°C in polypropylene syringes.
Int J Pharm Compound 2002 ; 6: 475-477.
2286 Journal Ben M, Trusley C, Kupiec TC, Trissel LA.
Physical and chemical stability of palonosetron hydrochloride with glycopyrrolate and neostigmine during simulated Y-site administration.
Int J Pharm Compound 2008 ; 12, 4: 368-371.
2291 Journal Yeh MK.
Degradation kinetics of neostigmine in solution.
Drug Dev Ind Pharm 2000 ; 26, 11: 1221-1226.
3372 Journal Hanci V, Ali Kiraz H, Ömür D, Ekin S, Uyan B, Yurtlu B.S.
Precipitation in Gallipoli: Sugammadex / Amiodarone & Sugammadex / Dobutamine & Sugammadex / Protamine.
Rev Bras Anestesiol 2013 ; 63, 1: 163-166.
3578 Manufacturer Cisplatin - Summary of Product Characteristics
Accord Healthcare 2011
3599 Manufacturer Glycopyrrolate Injection U.S.P. - Summary of Product Characteristics
Amco Amdipharm Mercry 2013
3644 Manufacturer Calcium gluconate® - Summary of Product Characteristics
Hameln Pharmaceuticals 2010
  Mentions Légales